Arrowhead Pharma stock holds steady as Cantor Fitzgerald reiterates Overweight rating
NeutralFinancial Markets

- Arrowhead Pharma's stock holds steady as Cantor Fitzgerald reiterates its Overweight rating, indicating a positive outlook for the company.
- This development is significant as it reflects investor confidence and may influence market perceptions, potentially leading to increased interest in Arrowhead Pharma's shares.
— via World Pulse Now AI Editorial System
